NM_004855.5:c.1527C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004855.5(PIGB):​c.1527C>T​(p.Ser509Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0776 in 1,601,842 control chromosomes in the GnomAD database, including 5,992 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1244 hom., cov: 32)
Exomes 𝑓: 0.074 ( 4748 hom. )

Consequence

PIGB
NM_004855.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.519

Publications

4 publications found
Variant links:
Genes affected
PIGB (HGNC:8959): (phosphatidylinositol glycan anchor biosynthesis class B) This gene encodes a transmembrane protein that is located in the endoplasmic reticulum and is involved in GPI-anchor biosynthesis. The glycosylphosphatidylinositol (GPI) anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene is thought to encode a member of a family of dolichol-phosphate-mannose (Dol-P-Man) dependent mannosyltransferases. [provided by RefSeq, Jul 2008]
CCPG1 (HGNC:24227): (cell cycle progression 1) Involved in positive regulation of cell cycle and positive regulation of cell population proliferation. Predicted to be integral component of membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2022]
DNAAF4-CCPG1 (HGNC:43019): (DNAAF4-CCPG1 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring dyslexia susceptibility 1 candidate 1 (DYX1C1) and cell cycle progression 1 (CCPG1) genes on chromosome 15. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 15-55355294-C-T is Benign according to our data. Variant chr15-55355294-C-T is described in ClinVar as [Benign]. Clinvar id is 1577109.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.519 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.203 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGBNM_004855.5 linkc.1527C>T p.Ser509Ser synonymous_variant Exon 12 of 12 ENST00000164305.10 NP_004846.4 Q92521
CCPG1NM_001204450.2 linkc.*926G>A 3_prime_UTR_variant Exon 9 of 9 ENST00000442196.8 NP_001191379.1 Q9ULG6-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGBENST00000164305.10 linkc.1527C>T p.Ser509Ser synonymous_variant Exon 12 of 12 1 NM_004855.5 ENSP00000164305.5 Q92521
CCPG1ENST00000442196.8 linkc.*926G>A 3_prime_UTR_variant Exon 9 of 9 2 NM_001204450.2 ENSP00000403400.3 Q9ULG6-5

Frequencies

GnomAD3 genomes
AF:
0.107
AC:
16291
AN:
152062
Hom.:
1241
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.207
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0778
Gnomad ASJ
AF:
0.115
Gnomad EAS
AF:
0.00192
Gnomad SAS
AF:
0.100
Gnomad FIN
AF:
0.0572
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0708
Gnomad OTH
AF:
0.101
GnomAD2 exomes
AF:
0.0758
AC:
18560
AN:
244836
AF XY:
0.0778
show subpopulations
Gnomad AFR exome
AF:
0.209
Gnomad AMR exome
AF:
0.0441
Gnomad ASJ exome
AF:
0.108
Gnomad EAS exome
AF:
0.000337
Gnomad FIN exome
AF:
0.0520
Gnomad NFE exome
AF:
0.0716
Gnomad OTH exome
AF:
0.0742
GnomAD4 exome
AF:
0.0745
AC:
107969
AN:
1449662
Hom.:
4748
Cov.:
29
AF XY:
0.0756
AC XY:
54555
AN XY:
721440
show subpopulations
African (AFR)
AF:
0.212
AC:
6971
AN:
32936
American (AMR)
AF:
0.0485
AC:
2119
AN:
43660
Ashkenazi Jewish (ASJ)
AF:
0.114
AC:
2954
AN:
25866
East Asian (EAS)
AF:
0.000253
AC:
10
AN:
39580
South Asian (SAS)
AF:
0.112
AC:
9473
AN:
84948
European-Finnish (FIN)
AF:
0.0557
AC:
2970
AN:
53344
Middle Eastern (MID)
AF:
0.0985
AC:
565
AN:
5734
European-Non Finnish (NFE)
AF:
0.0707
AC:
78076
AN:
1103656
Other (OTH)
AF:
0.0806
AC:
4831
AN:
59938
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
3908
7815
11723
15630
19538
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3000
6000
9000
12000
15000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.107
AC:
16309
AN:
152180
Hom.:
1244
Cov.:
32
AF XY:
0.105
AC XY:
7809
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.206
AC:
8566
AN:
41490
American (AMR)
AF:
0.0776
AC:
1186
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.115
AC:
399
AN:
3472
East Asian (EAS)
AF:
0.00193
AC:
10
AN:
5184
South Asian (SAS)
AF:
0.101
AC:
485
AN:
4824
European-Finnish (FIN)
AF:
0.0572
AC:
606
AN:
10596
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0709
AC:
4820
AN:
68010
Other (OTH)
AF:
0.0999
AC:
211
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
721
1442
2162
2883
3604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0910
Hom.:
503
Bravo
AF:
0.110
Asia WGS
AF:
0.0470
AC:
163
AN:
3476
EpiCase
AF:
0.0760
EpiControl
AF:
0.0758

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

PIGB-related disorder Benign:1
Nov 20, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
7.3
DANN
Benign
0.84
PhyloP100
-0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8043415; hg19: chr15-55647492; API